Cont roversies & Advances

Transcription

1 Cont roversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE The Seventeenth in the Series November 16-17, 2017 Montage Beverly Hills Beverly Hills, California PROGRAM DIRECTORS: Raj Makkar, MD, FACC, P.K. Shah, MD, MACC, Timothy D. Henry, MD, FACC, Alfredo Trento, MD, FACC, Saibal Kar, MD, FACC, John G. Harold, MD, MACC, Jon Kobashigawa, MD, FACC, Gregory P. Fontana, MD, FACC, Rahul Sharma, MD, and Garwood Gee, MD, FACC CO-SPONSORED BY Promedica International CME in cooperation with the California Chapter of the American College of Cardiology, the Arizona Chapter of the American College of Cardiology, the California Chapter of the Society of Thoracic Surgeons, and the International Academy of Cardiology

2 Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE PROGRAM DESCRIPTION We are proud to be celebrating the seventeenth annual Controversies and Advances in the Treatment of Cardiovascular Disease symposium! The two-day scientific program will offer realistic views on many controversial issues in cardiovascular disease today. Session topics will include atherosclerosis and dyslipidemia, innovation and technology, STEMI, NSTEMI, and cardiac arrest, drugs and devices, advanced heart failure, hypertension, clinical electrophysiology, sex differences in CVD, structural heart disease, and cardiac imaging. Sessions will include a combination of lectures, debates, and roundtable discussions. A faculty of internationally known leaders has been invited to share their knowledge and experiences with complex and controversial cases. TARGET AUDIENCE The conference is designed for cardiologists, interventional cardiologists, cardiovascular and thoracic surgeons, perfusionists, nurses, technicians and those involved in the diagnosis, treatment and care of individuals with controversial and complex cases of cardiac disease. LEARNING OBJECTIVES Upon completion of this course, participants should be able to: : : Analyze the latest advancements and emerging treatments for atherosclerosis and dyslipidemia : : Evaluate current advancements in digital medicine : : Examine the latest clinical trials in cardiogenic shock : : Debate the current controversies in drugs and devices including the FDA regulatory standards for approval : : Recognize the biomarkers for heart failure : : Reassess the silent symptoms of hypertension CME ACCREDITATION AND DESIGNATION : : Evaluate the latest updates in clinical electrophysiology : : Discuss considerations and examples of sex differences in FDA device approval : : Debate pros and cons of current treatments for mitral regurgitation and asymptomatic aortic stenosis : : Analyze updates in cardiac imaging and discuss the roles and limitations for various imaging modalities Promedica International is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Promedica International designates this live activity for a maximum of 16 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. Provider approved by the California Board of Registered Nursing, Provider #8495 for 16 Contact Hours. Category 1 CEUs for perfusionists will be determined by the American Board of Cardiovascular Perfusion and updated online at

3 The Seventeenth in the Series November 16 17, 2017 ABIM MOC ACCREDITATION Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16 Medical Knowledge MOC points and Patient Safety MOC credits in the American Board of Internal Medicine s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. COMMERCIAL SUPPORT This program is supported in part by educational grants and exhibits from industry, in accordance with the ACCME Standards for Commercial Support. At the time of printing, a complete list of commercial supporters was not available. Appropriate acknowledgement will be given to all supporters in meeting materials onsite. FACULTY DISCLOSURE In accordance with the ACCME Standards for Commercial Support, course directors, planning committees, faculty and all others in control of the educational content of the CME activity must disclose all relevant financial relationships with any commercial interest that they or their spouse/partner may have had within the past 12 months. If an individual refuses to disclose relevant financial relationships, they will be disqualified from being a part of the planning and implementation of this CME activity. Employees of a commercial interest with business lines or products relating to the content of the CME activity will not participate in the planning or any accredited portion of the conference. Disclosure will be made to all participants at the conference location, prior to the educational activity commencement. CULTURAL AND LINGUISTIC COMPETENCY This activity is in compliance with California Assembly Bill 1195 which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency. The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development. Cultural and linguistic competency was incorporated into the planning of this activity.

4 Faculty Program Directors Raj Makkar, MD, FACC P.K. Shah, MD, MACC Timothy D. Henry, MD, FACC Alfredo Trento, MD, FACC Saibal Kar, MD, FACC John G. Harold, MD, MACC Jon A. Kobashigawa, MD, FACC Gregory P. Fontana, MD, FACC Rahul Sharma, MD Garwood Gee, MD, FACC Local Faculty C. Noel Bairey Merz, MD, FACC Daniel S. Berman, MD, FACC David S. Cannom, MD, FACC Richard Cheng, MD, FACC Sumeet S. Chugh, MD, FACC Sam Dawkins, MD, PhD James Forrester, MD, FACC Eli S. Gang, MD, FACC Dael Geft, MD, FACC Jeffrey Goodman, MD, FACC Sean Hayes, MD Raj Khandwalla, MD, MA, FACC Asher Kimchi, MD, FACC Norman E. Lepor, MD, FACC Eduardo Marbán, MD, PhD, FACC Jignesh Patel, MD, PhD, FACC Charles Pollick, MD Florian Rader, MD, MSc, FACC Danny Ramzy, MD, PhD, FACC Konrad Schlick, MD Robin Shaw, MD, PhD, FACC Robert Siegel, MD, FACC Siddharth Singh, MD, MS Brennan Spiegel, MD, MSHS Charles Swerdlow, MD, FACC Balaji Tamarappoo, MD, PhD Sam Torbati, MD Ronald G. Victor, MD, FACC Xunzhang Wang, MD Invited Faculty Vinayak Bapat, FRCS, CTh Columbia University Medical Center New York, NY Michael Blaha, MD, MPH Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Cockeysville, MD John Brush, MD, FACC Sentara Healthcare Eastern Virginia Medical School Norfolk, VA Matthew Budoff, MD, FACC Harbor-UCLA Medical Center Torrance, CA Terri L. Cornelison, MD, PhD Center for Devices & Radiological Health U.S. Food and Drug Administration Silver Spring, MD Kenneth Ellenbogen, MD, FACC Virginia Commonwealth University Medical Center Richmond, VA C. Michael Gibson, MS, MD, FACC Beth Israel Deaconess Medical Center Boston, MA Marjorie Jenkins, MD, MEdHP, FACP U.S FDA Office of Women's Health Silver Spring, MD Jonathon A. Leipsic, MD University of British Columbia St. Paul's Hospital Vancouver, Canada Michael Mack, MD, FACC Baylor Scott & White Health Dallas, TX Francis Marchlinski, MD, FACC Hospital of the University of Pennsylvania University of Pennsylvania Bala Cynwyd, PA Matthew J. Price, MD, FACC Scripps Clinic La Jolla, CA Gilbert Raff, MD, FACC Beaumont Health Royal Oak, MI Ivan Rokos, MD, FACC UCLA-Olive View Altadena, CA John S. Rumsfeld, MD, PhD, FACC Chief Innovation Officer of the American College of Cardiology Washington, DC Erik Schelbert, MD, MS, FACC University of Pittsburgh Pittsburgh, PA Peter J. Schwartz, MD, FACC IRCCS Istituto Auxologico Italiano Milan, Italy Leslee Shaw, PhD, FACC Emory University School of Medicine Atlanta, GA Win Shen, MD, FACC Mayo Clinic Arizona Phoenix, AZ Gregg Stone, MD, FACC Columbia University Medical Center The Cardiovascular Research Foundation New York, NY Bill Tancer Studio City, CA Viviany Taqueti, MD, MPH, FACC Brigham and Women's Hospital Boston, MA Paul S. Teirstein, MD, FACC Scripps Clinic La Jolla, CA Jacob Tfelt-Hansen, MD, DMSc Copehagen University Hospital, Rigshospitalet Copenhagen, Denmark C. Michael Valentine, MD, FACC President Elect of the American College of Cardiology Washington, DC Michael Weber, MD, FACC SUNY Downstate Medical College Brooklyn, NY Joseph Witztum, MD University of California, San Diego La Jolla, CA Lunch Panel Faculty Frank Litvack, MD, FACC Cedars-Sinai Medical Center Los Angeles, CA Rhonda Robb Medtronic, Inc. Mounds View, MN Larry Wood Edwards Lifesciences Irvine, CA

5 Scientific Program Thursday, November 16 7:00 7:30 AM Registration, Continental Breakfast, and Visit Exhibits 7:30 7:45 AM Welcome Address Dr. John G. Harold Welcoming Dr. C. Michael Valentine, President Elect of the American College of Cardiology The Quadruple Aim: How Can the ACC Improve the Lives of Its Members? John G. Harold, MD, MACC C. Michael Valentine, MD, FACC 7:45 7:50 AM CA ACC Welcome Address Garwood Gee, MD, FACC 7:50 8:15 AM How We Can Dislodge CAD as the Nation s #1 Killer James Forrester, MD, FACC SESSION I: ATHEROSCLEROSIS AND DYSLIPIDEMIA P.K. Shah, MD, MACC 8:15 8:35 AM ANGPTL3: A Novel Lipid Modifying Target P.K. Shah, MD, MACC 8:35 8:55 AM Elevated LPa: How Important is it and What Can We do About it Now and in the Future? Joseph Witztum, MD 8:55 9:15 AM PCSK-9 Inhibitors: Are They Worth the Money? Michael Blaha, MD, MPH 9:15 9:35 AM Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It? 9:35 9:55 AM Roundtable Discussion 9:55 10:15 AM Break & Visit Exhibits SESSION II: CALIFORNIA CHAPTER ACC SATELLITE SYMPOSIUM: INNOVATION AND TECHNOLOGY Chairs: John G. Harold, MD, MACC Norman E. Lepor, MD, FACC 10:15 10:30 AM Introduction & Advances in Digital Medicine Raj Khandwalla, MD, FACC 10:30 10:45 AM ACC Innovation: A World Where Innovation and Knowledge Optimize Cardiovascular Care John S. Rumsfeld, MD, PhD, FACC 10:45 11:00 AM Virtually Better: How Virtual Reality is Easing Pain, Calming Nerves, and Lowering Blood Pressure Brennan Spiegel, MD, MSHS 11:00 11:15 AM Everyone s a Critic Bill Tancer 11:15 11:35 AM The APP-lication of Innovation and Technology to Every Day Clinical Practice A Personal Journey Vinayak Bapat, FRCS, CTh 11:35 AM 12:45 PM Lunch (This activity is not included in CME hours.) Panel Implication for Device and Drug Approval 21 st Century CURES Act Medical Device Tax Moderator: Frank Litvack, MD, FACC Panel: Gregory P. Fontana, MD, FACC Rhonda Robb, Larry Wood SESSION III: STEMI, NSTEMI, CARDIAC ARREST Timothy D. Henry, MD, FACC 12:45 1:05 PM Is Left Main and PCI Appropriate Therapy for Many or Most Patients with Multivessel CAD with or Without Diabetes Today? Gregg Stone, MD, FACC

6 1:05 1:20 PM Case Presentations Interventional Cardiology Fellows: Sam Dawkins, MD, PhD Richard Cheng, MD, FACC 1:20 1:40 PM New Horizons in Cardiogenic Shock: An Update of Clinical Trials 1:40 1:55 PM Timing of Revascularization for NSTEMI Timothy D. Henry, MD, FACC 1:55 2:15 PM Roundtable Discussion Timothy D. Henry, MD, FACC Ivan Rokos, MD, FACC 2:15 2:30 PM Break & Visit Exhibits SESSION IV: CONTEMPORARY CONTROVERSIES IN DRUGS AND DEVICES 2:30 3:00 PM Are the FDA Regulatory Standards for Approval of Medical Devices Lax? Insights from Recent Examples :: Bioresorbable Stents :: Cerebral Protection System :: PFO Closure 3:00 3:15 PM Roundtable Discussion Newer Generation Troponins When to Order and How to Interpret? John Brush, MD, FACC Timothy D. Henry, MD, FACC Ivan Rokos, MD, FACC Sam Torbati, MD 3:15 3:30 PM COMPASS Trial: Role of Rivaroxaban Plus Aspirin for Secondary Cardiovascular Protection: Will it Change Practice? C. Michael Gibson, MS, MD, FACC 3:30 3:50 PM Does IMPROVE-IT and FOURIER Confirm or Refute the LDL Hypothesis? SESSION V: CONTROVERSIES IN ADVANCED HEART FAILURE Jon A. Kobashigawa, MD, FACC Alfredo Trento, MD, FACC 3:50 4:10 PM Heart Failure Biomarkers, is it Better to Measure Muscle Health or Volume Overload? Robin Shaw, MD, PhD, FACC 4:10 4:20 PM Diastolic Dysfunction: Progress in the Treatment of Cardiac Amyloid Jignesh Patel, MD, PhD, FACC 4:20 4:40 PM Medical vs. Surgical Treatment for Restrictive Cardiomyopathy :: Medical Dael Geft, MD, FACC :: Surgical Danny Ramzy, MD, PhD, FACC 4:40 5:00 PM Roundtable Discussion Dael Geft, MD, FACC Jon A. Kobashigawa, MD, FACC Jignesh Patel, MD, PhD, FACC Danny Ramzy, MD, PhD, FACC Robin M. Shaw, MD, PhD, FACC Alfredo Trento, MD, FACC SESSION VI: HYPERTENSION Ronald G. Victor, MD, FACC Moderator: Florian Rader, MD, MSc, FACC 5:00 5:20 pm Rise, Fall, and Resurrection of Renal Denervation Michael Weber, MD, FACC

7 5:20 5:30 pm Discussion 5:30 5:50 pm Hypertension: The Not-So-Silent Killer Ronald G. Victor, MD, FACC 5:50 6:00 PM Discussion 6:00 PM Special Guest Entertainment: Dana Carvey (This activity is not included in CME hours.) Friday, November 17 7:00 7:25 AM Registration, Continental Breakfast, and Visit Exhibits 7:25 7:30 AM Welcome Address Program Directors: Raj Makkar, MD, FACC John G. Harold, MD, MACC SESSION VII: CLINICAL ELECTROPHYSIOLOGY Chairs: Sumeet S. Chugh, MD, FACC David S. Cannom, MD, FACC Eli S. Gang, MD, FACC Jeffrey S. Goodman, MD, FACC Charles Swerdlow, MD, FACC Xunzhang Wang, MD, FACC 7:30 7:50 AM Sudden Death in Athletes: Is Screening Justified? Jacob Tfelt-Hansen, MD, DMSc 7:50 8:10 AM Left Cardiac Sympathetic Denervation: Special Tool for Sudden Death Prevention Peter J. Schwartz, MD, FACC 8:10 8:30 AM Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Today Francis Marchlinski, MD, FACC 8:30 8:50 AM His Bundle Pacing: Where is it Going? Kenneth Ellenbogen, MD, FACC 8:50 9:10 AM ICDs for Non-Ischemic Cardiomyopathy: All in the Past? Win Shen, MD, FACC 9:10 9:30 AM The Cedars-Sinai Heart Institute: A Ten-Year Progress Report Eduardo Marbán, MD, PhD, FACC 9:30 9:50 AM Break & Visit Exhibits SESSION VIII: SEX DIFFERENCES IN CVD DRUG AND DEVICE APPROVAL AND USE C. Noel Bairey Merz, MD, FACC 9:50 10:00 AM Introduction and Overview C. Noel Bairey Merz, MD, FACC 10:00 10:10 AM Example of Sex Differences of Clinical Importance CRT Viviany Taqueti, MD, MPH, FACC 10:10 10:20 AM Considerations of Sex Differences in FDA Device Approval Terri L. Cornelison, MD, PhD 10:20 10:30 AM Overview of FDA Review, Approval, Post-Approval Monitoring and the FDA Snapshots Website Marjorie Jenkins, MD, MEdHP, FACP 10:30 11:00 AM Panel Discussion and Q&A 11:00 11:15 AM NBPAS: An Alternative to MOC Paul S. Teirstein, MD, FACC 11:15 AM 12:30 PM Lunch

8 November 16-17, 2017 SESSION IX: CONTROVERSIES IN STRUCTURAL HEART DISEASE Chairs: Raj Makkar, MD, FACC Saibal Kar, MD, FACC 12:30 12:50 PM PFO Closure Close Them All? Saibal Kar, MD, FACC Konrad Schlick, MD 12:50 1:10 PM Is it Time for a National Network of Valve Centers? Michael Mack, MD, FACC 1:10 1:20 PM What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It be Assessed? Robert Siegel, MD, FACC 1:20 1:50 PM Rapid Cross Fire Functional Mitral Regurgitation Treat the Valve or the Ventricle? Panel: Gregory P. Fontana, MD, FACC Saibal Kar, MD, FACC Michael Mack, MD, FACC Gregg Stone, MD, FACC 1:50 2:20 PM Rapid Cross Fire Management of Asymptomatic Aortic Stenosis and Mitral Regurgitation Who to Treat and How? Panel: Michael Mack, MD, FACC Matthew J. Price, MD, FACC Paul S. Teirstein, MD, FACC 2:20 2:40 PM Break SESSION X: UPDATE IN CARDIAC IMAGING Daniel S. Berman, MD, FACC 2:40 3:10 PM Roundtable Discussion Coronary CTA vs. Calcium Testing vs. High Sensitivity Troponins in Acute Chest Pain? Matthew Budoff, MD, FACC Gilbert Raff, MD, FACC Ivan Rokos, MD, FACC 3:10 3:30 PM HFPEF Echo with Strain vs. T1 MRI Mapping Erik Schelbert, MD, MS, FACC Siddharth Singh, MD, MS 3:30 3:45 PM :: FFR is Not the Gold Standard for Revascularization Decision-Making Paul S. Teirstein, MD, FACC :: FFR is the Gold Standard for Revascularization Decision-Making Matthew J. Price, MD, FACC 3:45 4:05 PM Update in Nuclear Imaging of Infiltrative Cardiomyopathy: Sarcoidosis and Amyloidosis Balaji Tamarappoo, MD, PhD 4:05 4:40 PM Stress SPECT/PET vs. Stress Echo in Patients with Suspected or Known CAD Sean Hayes, MD Charles Pollick, MD 4:40 5:00 PM Uncertain Results on Coronary CTA: Further Assessment with FFR CT or Ischemia Testing? Leslee Shaw, PhD, FACC Jonathon A. Leipsic, MD 6:30 10:30 pm California Chapter of the American College of Cardiology Awards Dinner featuring the entertainer Charo Seating limited. Register now! Registration: ACC member: $40 Member Guest: $60 Register for the dinner: or administrator@caacc.org

9 Registration Information $595 Physician/Industry $395 Nurse/Resident/Technician $395 ACC National Member $195 California Chapter ACC Member/ Cardiac Care Associate $395 CASTS Member $195 CASTS Associate Member Registration fees include breakfasts and lunches, as well as scientific program materials. Please make checks payable to Promedica International CME in U.S. dollars drawn on a U.S. bank. Visa, MasterCard, Discover and American Express credit cards are also accepted. Registrations should be faxed, mailed or submitted online at To register, please complete the attached form and mail or fax to: Promedica International CME 300 Carlsbad Village Dr., Suite 108A-326 Carlsbad, CA Tel: (760) , Fax: (760) Rlaw@promedicacme.com Refunds All cancellations must be submitted in writing and refunds will be subject to a $100 administration charge. Cancellations cannot be accepted over the telephone. Refunds will not be available beginning 45 days prior to the symposium. Hotel Accommodations A special room rate of $395 per night plus taxes for single or double occupancy is available for program participants at the Montage Beverly Hills. Reserve your room prior to the cutoff date of October 30, 2017 by calling Mention your affiliation with the Controversies symposium to receive the special rate. Activity Evaluation Evaluation by online questionnaire will address content, presentation, and future educational needs. Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE November 16 17, 2017 Montage Beverly Hills - Beverly Hills, California Visit us at for convenient online registration. Physician/Industry: $595 Nurse/Resident/ Technician: $395 ACC National Member: $395 California Chapter ACC Member/Cardiac Care Associate: $195 CASTS Member: $395 CASTS Associate Member: $195 All fees in US dollars drawn on US banks: P Check Enclosed P Visa/MasterCard P American Express P Discover Credit Card Number Expiration Date Signature First/Last Name P MD PRN PCCP PNP Institution Mailing Address City/State/Zip/Country Telephone Fax Address Specialty Please mail or fax to: Promedica International CME, 300 Carlsbad Village Dr., Suite 108A-326, Carlsbad, CA Tel: (760) , Fax: (760) , Rlaw@promedicacme.com

10 Promedica International CME 300 Carlsbad Village Dr., Suite 108A-326 Carlsbad, CA Cont roversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE The Seventeenth in the Series November 16 17, 2017 Montage Beverly Hills Beverly Hills, California WHAT THEY RE SAYING: : : Topics were relevant to clinical practice and related sessions illuminated some of the most vexing issues faced on a daily basis. : : Consistently great conference year after year! : : The program was outstanding and had practical applications for my daily practice. : : A really wonderful, educational, and thought-provoking conference with excellent speakers. : : I was impressed by the evidence-based practice as a result of incredible research all around the world! : : The topics were pertinent and I was engaged and stimulated by the excellent presentations. Presort Standard U.S. Postage PAID Permit 1948 San Diego CA